Metagenomi Therapeutics, Inc.
MGX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001785279
In the last 90 days, Metagenomi Therapeutics, Inc. insiders filed 1 open-market purchase and 3 sales; 43 institutions reported holding it in 13F filings for Q2 2026, worth $7.45M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Metagenomi Therapeutics, Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 54
- +4 vs. Q1 2024
- Shares held
- 12.2M
- −1.15M (−8.6%) vs. Q1 2024
- Total value
- $49.6M
- −$90.7M (−64.7%) vs. Q1 2024
- New holders
- 15
- 15 more added
- Sold out
- 11
- 14 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MGX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 43 | $7.45M |
| Q1 2026 | 48 | $8.65M |
| Q4 2025 | 56 | $11.0M |
| Q3 2025 | 58 | $14.2M |
| Q2 2025 | 69 | $10.4M |
| Q1 2025 | 79 | $13.5M |
| Q4 2024 | 77 | $38.8M |
| Q3 2024 | 67 | $25.3M |
| Q2 2024 | 54 | $49.6M |
| Q1 2024 | 50 | $140.3M |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Metagenomi Therapeutics, Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Novo Holdings A/S | 1,800,000 | $7.34M | 0.40% | +60,825+3.5% | Added |
| Ra Capital Management, L.P. | 1,477,749 | $6.03M | 0.08% | −266,666−15.3% | Reduced |
| Farallon Capital Management, L.L.C. | 1,343,201 | $5.48M | 0.03% | 00.0% | Unchanged |
| PFM Health Sciences, LP | 1,267,002 | $5.17M | 0.28% | 00.0% | Unchanged |
| HHLR Advisors, Ltd.SuperinvestorHHLR Advisors (Hillhouse) | 777,768 | $3.17M | 0.08% | 00.0% | Unchanged |
| Citadel Advisors LLC | 729,852 | $2.93M | 0.00% | +5,951+0.8% | Added |
| Eventide Asset Management, LLC | 583,041 | $2.38M | 0.04% | 00.0% | Unchanged |
| Sozo Ventures GP II, L.P. | 581,577 | $2.37M | 0.97% | 00.0% | Unchanged |
| Deep Track Capital, LP | 466,232 | $1.90M | 0.06% | 00.0% | Unchanged |
| BlackRock Inc. | 420,242 | $1.71M | 0.00% | +305,918+267.6% | Added |
| Norges Bank | 360,202 | $1.47M | 0.00% | +252,310+233.9% | Added |
| Millennium Management LLC | 313,162 | $1.23M | 0.00% | −434,386−58.1% | Reduced |
| Artal Group S.A. | 300,000 | $1.22M | 0.03% | 00.0% | Unchanged |
| Pura Vida Investments, LLC | 270,618 | $1.04M | 1.26% | −190,665−41.3% | Reduced |
| Frazier Life Sciences Management, L.P. | 245,692 | $1.00M | 0.05% | −33,333−11.9% | Reduced |
| Vanguard Group Inc | 216,166 | $882.0K | 0.00% | +36,619+20.4% | Added |
| ExodusPoint Capital Management, LP | 192,763 | $786.0K | 0.01% | −34,793−15.3% | Reduced |
| Marshall Wace, LLP | 168,639 | $688.0K | 0.00% | −14,388−7.9% | Reduced |
| Geode Capital Management, LLC | 164,235 | $670.1K | 0.00% | +77,472+89.3% | Added |
| Point72 Asset Management, L.P. | 99,002 | $403.9K | 0.00% | −272,098−73.3% | Reduced |
| Charles Schwab Investment Management Inc | 45,111 | $184.1K | 0.00% | +14,963+49.6% | Added |
| Morgan Stanley | 44,718 | $182.4K | 0.00% | +35,513+385.8% | Added |
| Jacobs Levy Equity Management, Inc | 44,156 | $180.2K | 0.00% | +44,156 | New |
| Two Sigma Investments, LP | 37,694 | $153.8K | 0.00% | +17,535+87.0% | Added |
| State Street Corp | 30,474 | $124.3K | 0.00% | +30,474 | New |
| New York State Common Retirement Fund | 26,600 | $108.5K | 0.00% | +26,600 | New |
| Resolute Partners Group | 26,500 | $108.1K | 0.03% | +16,500+165.0% | Added |
| Wells Fargo & Company | 26,312 | $107.4K | 0.00% | +1,418+5.7% | Added |
| Hudson Bay Capital Management LP | 17,000 | $69.4K | 0.00% | −49,666−74.5% | Reduced |
| XTX Topco Ltd | 16,244 | $66.3K | 0.01% | +16,244 | New |
| Bramshill Investments, LLC | 15,500 | $63.2K | 0.01% | −10,000−39.2% | Reduced |
| Northern Trust Corp | 13,596 | $55.5K | 0.00% | +543+4.2% | Added |
| Squarepoint Ops LLC | 10,202 | $41.6K | 0.00% | −16,286−61.5% | Reduced |
| Cerity Partners LLC | 10,000 | $40.8K | 0.00% | +10,000 | New |
| Rhumbline Advisers | 6,423 | $26.2K | 0.00% | +6,423 | New |
| BNP Paribas Arbitrage, SA | 5,543 | $22.6K | 0.00% | +5,543 | New |
| Acadian Asset Management LLC | 5,440 | $22.0K | 0.00% | +5,440 | New |
| US Bancorp | 4,500 | $18.4K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 4,375 | $17.9K | 0.00% | +3,919+859.4% | Added |
| Corebridge Financial, Inc. | 3,395 | $13.9K | 0.00% | +3,395 | New |
| Bank of America Corp | 3,295 | $13.4K | 0.00% | +146+4.6% | Added |
| JPMorgan Chase & Co | 2,689 | $11.0K | 0.00% | −11,058−80.4% | Reduced |
| Point72 (DIFC) Ltd | 2,295 | $9.36K | 0.00% | +2,295 | New |
| Barclays PLC | 2,166 | $8.84K | 0.00% | +2,166 | New |
| UBS Group AG | 2,158 | $8.80K | 0.00% | +478+28.5% | Added |
| Citigroup Inc | 1,390 | $5.67K | 0.00% | −15,278−91.7% | Reduced |
| Qube Research & Technologies Ltd | 1,053 | $4.30K | 0.00% | −15,614−93.7% | Reduced |
| Ameritas Investment Partners, Inc. | 618 | $2.52K | 0.00% | +618 | New |
| Legal & General Group Plc | 491 | $2.00K | 0.00% | −9,509−95.1% | Reduced |
| Royal Bank of Canada | 603 | $2.00K | 0.00% | +603 | New |
| California State Teachers Retirement System | 457 | $1.86K | 0.00% | +457 | New |
| Amalgamated Bank | 218 | $1.00K | 0.00% | +218 | New |
| Principal Securities, Inc. | 54 | $220 | 0.00% | 00.0% | Unchanged |
| Larson Financial Group LLC | 50 | $204 | 0.00% | 00.0% | Unchanged |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −350,859−100.0% | Sold out |
| Altitude Crest Partners Inc. | 0 | $0 | 0.00% | −133,333−100.0% | Sold out |
| Ghisallo Capital Management LLC | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −52,058−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −31,477−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −22,009−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −12,330−100.0% | Sold out |
| Teacher Retirement System of Texas | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Assetmark, Inc | 0 | $0 | 0.00% | −952−100.0% | Sold out |
| Macquarie Group Ltd | 0 | $0 | 0.00% | −355−100.0% | Sold out |